EndoRotor for Squamous Cell Carcinoma
Squamous Cell Carcinoma (SCC)
Key Facts
About Interscope
Interscope is a commercial-stage medical device company focused on advanced endoscopic resection tools. Its flagship product, the EndoRotor®, is a single device that simultaneously dissects, resects, and collects tissue, offering a novel approach for procedures like pancreatic necrosectomy and the treatment of difficult gastrointestinal lesions. The device holds both a 510(k) clearance for Endoscopic Powered Resection (EPR) and a De Novo authorization for Powered Endoscopic Debridement (PED) in the US, positioning it as a specialized tool for complex interventional gastroenterology. The company is actively conducting clinical studies to expand the device's indications, including for refractory dysplastic Barrett's esophagus.
View full company profileTherapeutic Areas
Other Squamous Cell Carcinoma (SCC) Drugs
| Drug | Company | Phase |
|---|---|---|
| Skinject Patch | Skinject | Research |